MINI REVIEW
Endothelin: a new vasoactive ocular peptide
The retinal vasculature and autoregulation The tone of most blood vessels in the body is regulated by means of the autonomic nervous system. The vasculature of the human retina, however, lacks extrinsic innervation even though autonomic receptors are present in the walls.' Vessel calibre and local blood flow are normally regulated by nonnervous mechanisms intrinsic to the retina. This autoregulatory process helps preserve a uniform retinal blood flow in the presence of a variable perfusion pressure and matches it to tissue oxygen and metabolic requirements. 2 The failure of autoregulation is an important and often early feature of retinal vascular disease and can be influenced in some instances by laser photocoagulation, for example diabetic retinopathy.3
Retinal pericytes The effector cells in autoregulation are the vascular smooth muscle (VSM) cells, and their tone and active contraction control vessel diameter, blood flow, and tissue oxygen levels. In most mammalian circulations the precapillary arteriolar sphincters play a pivotal role in the control of blood flow to the capillary bed.4 However these strategic collars of smooth muscle cells are not a feature of the retinal circulation in the primate eye. There is now a considerable body of evidence to suggest that retinal pericytes, which are the microvascular correlates of VSM cells, are responsible for changes in retinal capillary tone and local blood flow. Pericytes have been shown to contain the smooth muscle isoforms of both actin and myosin' and cGMP dependent protein kinase,6 thus providing further documentation of morphological and biochemical similarities to smooth muscle and for a contractile role. Pericytes have also been shown to deform substrata in vitro7 demonstrating that these cells have the potential to contract and exert significant amounts of traction in vivo.
Endothelin 1: an endothelium-derived vasoactive agent It is now known that vascular endothelium can influence vascular tone and blood flow by the production of potent vasodilators8 and vasoconstrictors9 which affect the underlying smooth muscle. In 1988 Yanagisawa et al isolated and characterised an endothelium-derived 21 amino acid vasoconstrictor polypeptide which they termed endothelin.'0 Endothelin is a member of a family of peptides arising from three preproendothelin species which, after proteolysis, yield three isoforms termed endothelin 1, 2, and 3 (ET1, ET2, and ET3)." ETL is the most potent constrictor known of large and small vessels particularly those of the kidney and has major biological effects on VSM cells'2 and the renal mesangial cell which is a pericyte. 13 The mechanism of action of ET1, which has been extensively studied in the renal mesangial cell, suggests that ET1 induced contraction occurs as a result of pharmacomechanical coupling to ET1 receptors with activation of the phosphoinositide cascade involving phospholipase A2 to produce prostaglandins E2, F2a and thromboxane A2. ' 26 These observations suggest that ETI production by vascular endothelium and the contractile response of the underlying effector cells may be flawed in diabetes and possibly implicated in the pathogenesis of diabetic microangiopathy.
ET1 and retinal vascular endothelial cell-pericyte responses Endothelial cell-pericyte interactions are now considered at least in part to be responsible for the biological control of endothelial cell proliferation as shown by electron microscopic studies of growing blood vessels in healing wounds,27 and in experimental choroidal neovascularistion.28 There is a growing body of evidence that endothelial cells and pericytes influence each other's replicative and biosynthetic behaviour,29 and co-culture of these cells results in activation of transforming growth factor ,3 (TGF,) which in turn inhibits endothelial cell proliferation.3 TGF,3 itself can cause increased transcription of ETI mRNA showing that biofeedback mechanisms exist allowing these growth factors to influence each other's production and participate in cellular interactions.3' As ETL is known to have mitogenic effects on retinal pericytes,24 it is interesting to speculate that activation of TGF, in vivo can in turn increase the expression of ET1 mRNA thereby influencing pericyte replication, maintenance, and health. The complexity of such interactions involving growth factors such as ET1 and TGF,3 has major implications in the pathophysiology of diseases such as diabetes and hypertension where there may be a derangement in endothelial cell-pericyte interactions with consequent effects on the function of the microcirculation. The study of retinal vasculature and retina derived growth factors should improve our understanding of disease pathogenesis and pave the way for the development of better therapeutic modalities.
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